Titles listed in order of publication—
January/February 1998
Page Title
1 Determination of Methyl tert-Butyl Ether and tert-Butyl Alcohol in Human Urine by High-Temperature Purge-and-Trap Gas Chromatography–Mass Spectrometry
6 Drug Testing with Alternative Matrices I. Pharmacological Effects and Disposition of Cocaine and Codeine in Plasma, Sebum, and Stratum Corneum
18 Quantitative Gas Chromatographic Analysis of [1-(4-Piperidinyl)-1,3-dihydro-2H-benzimidazole-2-one], the Basic Metabolite of Bezitramide (Burgodin®), in Human Urine
27 Diagnostic Performance of the EMIT-tox® Benzodiazepine Immunoassay, FPIA Serum Benzodiazepine Immunoassay, and Radioreceptor Assay in Suspected Acute Poisoning
33 Optical Isomer Analysis of 3,4-Methylenedioxyamphetamine Analogues and their Stereoselective
Disposition in Rats
40 Performance of Abusign™ Drugs-of-Abuse Slide Tests with Particular Emphasis of Concentrations Near the Cutoff: Comparison with FPIA-ADx and Confirmation of Results with GC–MS
45 Presence of Phenylethylamine in Hallucinogenic Psilocybe Mushroom: Possible Role in Adverse Reactions
50 Oxaprozin Cross-Reactivity in Three Commercial Immunoassays for Benzodiazepines in Urine
55 Identification of New Urinary Metabolites of Famprofazone in Humans
61 Urinalysis of Body Packers in Japan
66 TECHNICAL NOTE: Modification of Hewlett-Packard® ChemStation (G1034C version C.02.00 and G1701AA version C.02.00 and C.03.00) Data Analysis Program for Addition of Automatic Extracted Ion Chromatographic Groups
72 CASE REPORT: A Cyproheptadine Fatality
75 CASE REPORT: Application of Hair Analysis to Document Coercive Heroin Administration to a Child
78 LETTER TO THE EDITOR: Testing for Driving Under the Influence of Ethanol: Misleading Results Caused by Ether
80 LETTER TO THE EDITOR: Positive Cannabis Results in Urine and Blood Samples after Consumption of Hemp Food Products
March/April 1998
Page Title
89 Nitrite Adulteration of Workplace Urine Drug-Testing Specimens I. Sources and Associated Concentrations of Nitrite in Urine and Distinction Between Natural Sources and Adulteration
 96 A Rapid, Sensitive Method for the Quantitation of N-Acetyl-S-(2-Hydroxyethyl)-l-Cysteine in Human Urine Using Isotope-Dilution HPLC–MS–MS
105 A Barbiturate Screening Assay for the Abbott AxSYM Analyzer
112 Detection and Determination of Theobromine and Caffeine in Urine after Administration of Chocolate-Coated Peanuts to Horses
117 Survey on Drugs-of-Abuse Testing in the European Union
127 Screening Procedure for b-Adrenergic Drugs in Sports Drug Testing by Immunological Methods
135 The Feasibility of the Detection and Quantitation of b-Adrenergic Blockers by Solid-Phase Extraction and Subsequent Derivatization with Methaneboronic Acid
142 Morphine Formation from Ethylmorphine: Implications for Drugs-of-Abuse Testing in Urine
148 Development and Evaluation of Immunochromatographic Rapid Tests for Screening of Cannabinoids, Cocaine, and Opiates in Urine
156 Incorporation of Isotopically Labeled Cocaine in to Human Hair: Race as a Factor
166 CASE REPORT: Suicide with the Veterinary Drug Acepromazine
169 CASE REPORT: Recent Paramethoxyamphetamine Deaths
173 LETTER TO THE EDITOR: 6-Acetylmorphine Detection in Postmortem Cerebrospinal Fluid
176 LETTER TO THE EDITOR: Stabilization of Blood Cyanide
179 LETTER TO THE EDITOR: Analysis of Hempen Ale™ for Cannabinoids
May/June 1998
Page Title
181 Ethanol Content of Various Foods and Soft Drinks and their Potential for Interference with a Breath-Alcohol Test
184 Lack of Association Between Urinary Creatinine and Ethanol Concentrations and Urine/Blood Ratio of Ethanol in Two Successive Voids from Drinking Drivers
191 Dramatic Signal Reduction in Ion-Mobility Spectrometry by Residues of Solvents
197 Determination of Flunitrazepam and its Main Metabolites in Serum and Urine by HPLC after Mixed-Mode Solid-Phase Extraction
203 Determination of Chlorpyrifos, Chlorpyrifos Oxon, and 3,5,6-Trichloro-2-Pyridinol in Rat and Human Blood
211 Gas Chromatographic Method for the Simultaneous Determination of S-p-Toluylmercapturic Acid and
S-Phenylmercapturic Acid in Human Urine
215 Identification and Determination of Opipramol Metabolites in Plasma and Urine
220 Cocaine, Nicotine, Caffeine, and Metabolite Plasma Concentrations in Neonates
225 Background Levels of Bromide in Human Blood
231 Dose–Concentration Relationships in Hair from Subjects in a Controlled Heroin-Maintenance Program
237 GC and GC–MS Determination of Fluoroacetic Acid and Phenoxy Acid Herbicides via Triphasal Extractive Pentafluorobenzylation Using a Polymer-Bound Phase-Transfer Catalyst
246 CASE REPORT: Unusual Death Attributed to the Combined Effects of Chloral Hydrate, Lidocaine, and Nitrous Oxide
248 CASE REPORT: Analysis of Fenthion in Postmortem Samples by HPLC with Diode-Array Detection and GC–MS Using Solid-Phase Extraction
253 LETTER TO THE EDITOR: Comparison of Fentanyl Concentrations in Unembalmed and Embalmed Liver Samples
254 LETTER TO THE EDITOR: Buflomedil is a Potent Interfering Substance in Immunoassays of Tricyclic Antidepressants
255 LETTER TO THE EDITOR: Improved Procedure for Overcoming Nitrite Interferences in GC–MS Procedures for Cannabinoids
257 LETTER TO THE EDITOR: Mass-to-Charge Ratio Misassignments of Molecular Ions in Ion-Trap Mass Spectrometry
260 LETTER TO THE EDITOR: Suicide by Tramadol Overdose
July/August 1998
Page Title
261 A Preliminary Study on the Distribution of Morphine and Its Glucuronides in the Subcompartments of Blood
265 Enantiomeric Determination of Amphetamine and Methamphetamine in Urine by Precolumn Derivatization with Marfey’s Reagent and HPLC
270 CEDIA dau Benzodiazepine Screening Assay: A Reformulation
274 Laxative Poisoning: Toxicological Analysis of Bisacodyl and Its Metabolite in Urine, Serum, and Stool
279 Applications of an HPLC–DAD Drug-Screening System Based on Retention Indices and UV Spectra
290 Identification Limits for Volatile Organic Compounds in the Blood by Purge-and-Trap GC–FTIR
296 Evidence of Gestational Heroin Exposure by Comparative Analysis of Fetal and Maternal Body Fluids, Tissues, and Hair in a Heroin-Related Death
299 Detection of Amphetamine and Methamphetamine Following Administration of Benzphetamine
310 Methylephedrine Concentrations in Blood and Urine Specimens
314 Detection of Drugs of Abuse in Nails
319 Fast Screening for Drugs of Abuse by Solid-Phase Extraction Combined with Flow-Injection Ionspray-Tandem Mass Spectrometry
329 D9-THC Metabolites in Meconium: Identification of 11-OH-D9-THC, 8b,11-diOH-D9-THC, and 11-nor-D9-THC-9-COOH as Major Metabolites of D9-THC
336 CASE REPORT: Quantitative Analysis of Aconitum Alkaloids in the Urine and Serum of a Male Attempting Suicide by Oral Intake of Aconite Extract
341 LETTER TO THE EDITOR: False Results from SPEC® • LTD™ • MP3 Microcolumns for Screening Opiates—It’s Not the Heat; It’s the Humidity
September 1998
Page Title
345 2C-B: A New Psychoactive Phenylethylamine Recently Discovered in Ecstasy Tablets Sold on the Swiss Black Market
355 Cocaine and Cocaethylene Binding to Human Liver
359 Simultaneous Extraction of Selected Benzodiazepines and Benzodiazepine-Glucuronides from Urine by Immunoadsorption
363 A New Specific Method to Detect Cyanide in Body Fluids, Especially Whole Blood, by Fluorimetry
367 Development and Validation of a Screening Method for DES, Zeranol, and b-Zearalanol in Bovine Urine by HRGC–MS and Evaluation of Robustness for Routine Survey of the Brazilian Herd
374 Isotope Dilution Gas Chromatographic–Mass Spectrometric Measurement of Tricyclic Antidepressant Drugs. Utility of the 4-Carbethoxyhexafluorobutyryl Derivatives of Secondary Amines
383 Identification of Metabolites of Nerve Agent VX in Serum Collected from a Victim
389 Improved Solid-Phase Extraction of Methadone and Its Two Major Metabolites from Whole Blood
393 False-Positive LSD Testing in Urine Samples from Intensive Care Patients
396 Simple Analysis of Tetracyclic Antidepressants in Blood using Headspace-Solid-Phase Microextraction and GC–MS
401 LETTER TO THE EDITOR: Nitrite Contamination in Urine Collection Kit Component—Absorbent Sheet
403 LETTER TO THE EDITOR: Evaluation of DRI Drug-of-Abuse Reagents on the Hitachi 911
October 1998
Page Title
406 The Incorporation of Drugs into Hair: Relationship of Hair Color and Melanin Concentration to Phencyclidine Incorporation
414 Quantitation of Cocaine in Human Hair: The Effect of Centrifugation of Hair Digests
418 Amphetamines in Hair by Enzyme-Linked Immunosorbent Assay
425 Evaluation of Acetylcodeine as a Specific Marker of Illicit Heroin in Hair
430 Buprenorphine-Related Deaths Among Drug Addicts in France: A Report on 20 Fatalities
435 Cocaine and Metabolite Concentrations in Plasma During Repeated Oral Administration: Development of a Human Laboratory Model of Chronic Cocaine Use
445 Differentiating New Marijuana Use From Residual Drug Excretion in Occasional Marijuana Users
455 The Effect of Oral Dehydroepiandrosterone (DHEA) on the Urine Testosterone/Epitestosterone (T/E) Ratio in Human Male Volunteers
460 In Vivo Adulteration: Excess Fluid Ingestion Causes False-Negative Marijuana and Cocaine Urine Test Results
474 Determination of Five Abused Drugs in Nitrite-Adulterated Urine by Immunoassays and Gas Chromatography–Mass Spectrometry
481 Urinary Excretion of d-Amphetamine Following Oral Doses in Humans: Implications for Urine Drug Testing
487 An Evaluation of the Role of ROC Plots in the Prediction of Heroin Use from Total Codeine and Total Morphine Concentrations in Urine
493 A Multiple-Site Laboratory Evaluation of Three On-Site Urinalysis Drug-Testing Devices
503 Laboratory Validation Study of Drug Evaluation and Classification Program: Alprazolam, d-Amphetamine, Codeine, and Marijuana
515 Stability of Phencyclidine in Stored Blood Samples
520 Stability Study of LSD Under Various Storage Conditions
526 TECHNICAL NOTE: Detection of Methadone, Methadone Metabolites, and Other Illicit Drugs of Abuse in Hair of Methadone-Treatment Subjects
531 CASE REPORT: Detection of Doxepin and Its Major Metabolite Desmethyldoxepin in Hair Following Drug Therapy
537 CASE REPORT: Disposition of Valproic Acid in a Case of Fatal Intoxication
541 CASE REPORT: Distribution of Paroxetine in Three Postmortem Cases
545 CASE REPORT: Fatal Multiple Drug Intoxication Following Acute Sertraline Use
November/December 1998
549 Determination of Common Drugs of Abuse in Body Fluids Using One Isolation Procedure and Liquid Chromatography–Atmospheric-Pressure Chemical-Ionization Mass Spectrometry
559 Benzodiazepines: Toxic Serum Concentrations in Positive Enzyme Immunoassay Responses
567 In Vivo Formation of Codeinone-Glutathione Adduct: Isolation and Identification of a New Metabolite from the Bile of Codeine-Treated Guinea Pig
573 Validation of an Automated Microplate Enzyme Immunoassay for Screening of Postmortem Blood for Drugs of Abuse
580 Occurrence of Cocaine in Urine of Substance-Abuse Treatment Patients
587 Relative Binding of Therapeutic Drugs by Sera of Seven Mammalian Species
591 Determination of Bromvalerylurea and Its Metabolites in Biological Samples by Frit-Fast Atom Bombardment Liquid Chromatography–Mass Spectrometry
596 Caffeine Demethylation Monitoring Using a Transdermal Sweat Patch
601 Evaluation of the Diagnostic Performance of the Boehringer Mannheim CEDIA® LSD Assay
605 CASE REPORT: Determination of Olanzapine in a Postmortem Case
610 LETTER TO THE EDITOR: Organochlorine Pollutants in Human Hair
612 LETTER TO THE EDITOR: Plasma Concentrations after a Clomipramine Intoxication

| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |